Medical Cannabis MATT WEBSTER DO, MS

Similar documents
The Shifting Federal Regulation of Cannabis Products

Medical Marijuana. Gina C. Guzman, MD, DBIM, FALU, FLMI. Munich Re US (Life) 17 Nov 2016

Cannabis and What we Know. Bonnie Schnittker RN PHN Public Health Nurse October 20, 2017

Outcome. Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana. Connie J. Cerilli, APRN, FNP-C

Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana. Connie J. Cerilli, APRN, FNP-C

Frequently Asked Questions

Curious about Cannabis? Navigating the cannabis landscape in Pennsylvania LINDSEY MESTON, PHARMD ASHLEY FIRM, PHARMD

Medical Marijuana. Navigating Medical Marijuana in Workers Compensation

MEDICAL MARIJUANA: WHAT S THE EVIDENCE?

Research on Cannabis and PD: Is there any evidence?

Medical Marijuana Consent Form

The Return of Medicinal Cannabis

Use of Cannabinoids in Medical Practice

Medical Marijuana Update Chris Belletieri, DO

Federal Law: Marijuana

AGENDA. 9:00 Sign-in and introductions 9:15 Marijuana 10:30 Break 10:45 Opioid Prevention 11:30 Discussion & Wrap-Up

Medicinal Cannabis. Patient Log Book. Record your cannabis use and find the right dose

Northern California Chapter, ACP Update In Medicine

The Sale of Cannabis in Pharmacies. Michael H. Ghobrial, PharmD, JD Associate Director, Health Policy American Pharmacists Association

Medical Cannabis: A Patient Primer

Medical Marijuana: The Move to Schedule II

ADVANCED CLINICAL CANNABINOID PROVIDER EXAM ACCP

Consumer Information Cannabis (Marihuana, marijuana)

Objectives. 1. Review controversy 2. Pathophysiology 3. Indications for Use 4. Adverse Effects 5. How Patients Access

Medicinal cannabis. What is medicinal cannabis? What are cannabinoids? The endocannabinoid system

Medical Marijuana Martin P. Eason MD, JD Associate Chief of Staff for Education Mountain Home VA Medical Center. Disclosure.

4/15/2019. US States with Marijuana Laws in Have ACOG and SMFM taken notice? THE EFFECTS OF MARIJUANA USE ON PREGNANCY AND LACTATION

Is the most common illicit drug used in the United States. After a period of decline in the last decade, its use has been increasing among young

PATIENT QUESTIONNAIRE

Does Legality equal Legitimacy? The challenges of fostering safe practice with state legalization of marijuana

POLICY NUMBER: POL 153

Marijuana and Adolescents: Truth and Consequences. Disclosure Statement OBJECTIVES. Secondary Objectives. State of Marijuana in US

A look at Marijuana in 2014

This questionnaire will ask you about approved medical use of extracts and tinctures of cannabis at national level.

Medical Cannabis Program. Dr. Maureen Small Co Medical Director Andrea Sundberg Program Coordinator

Doc, will you sign my medical. Fellow in Hematology/Medical Oncology General Internal Medicine Grand Rounds

Medical Marihuana for Patients in the Lymphoma Setting. Speakers: Ruth Turner, RN, Con Rob Laister, PhD

The Effects known & unknown of Marijuana in Older Adults. Danielle Fixen, PharmD, BCGP, BCPS University of Colorado School of Pharmacy

Cannabidiol as a potential treatment for anxiety disorders. Esther Blessing, MD PhD

Marijuana and the Chronic Non-Cancer Pain Patient

Pennsylvania House of Representatives. Joint Health and Judiciary Committee Hearing. Medical Cannabis - Health Care Forum

Act 16 and Medical Cannabis in Pennsylvania

Learning Objectives 1/8/2019. Therapeutic Potential of the Marijuana-Derived Cannabinoids THC and CBD. Disclosures. Outline. Take home messages

Cannabidiol, or CBD, Benefits for Pain, Mental Illness & Anxiety

INTRODUCTION WHAT IS MARIJUANA 2/28/2018

History of Medical Cannabis in Nursing

Medical Marijuana. 1. is a plant species, variety known as hemp. 3. Tetrahydrocannabinol is an aromatic with low water solubility.

CANNABIS AND CANNABINOIDS: 2017 REPORT, U.S. NATIONAL ACADEMIES OF SCIENCES, ENGINEERING AND MEDICINE

Therapeutic Cannabis in New Hampshire. Number to text: Goals/Objectives. Survey. WMUR Granite State Poll (February 2013) 3/29/2018

Recent trends in medical cannabis use in Canada

Changing the Drug Enforcement Administration (DEA) Schedule of Tetrahydrocannabinol (THC), Cannabidiol and Combinations to Promote Research

These documents were created to support the work of the Coalition of Colorado Campus Alcohol and Drug Educators. We welcome prevention teams at

MEDICAL CANNABIS IN MINNESOTA

8/31/2016. Workplace Implications of Marijuana in the US. Goal

Acknowledgements: What it is What it s not. Cannabis Evidence Series. Evidence-informed decision-making

PATIENT INTAKE FORM. Name: Address: Town: State: Zip Code: MMJ Card #: Exp. Date: Drivers License #: Exp. Date: Home Phone: Cell:

Marijuana. Module 4 ALLIED TRADES ASSISTANCE PROGRAM PREVENTATIVE EDUCATION: SUBSTANCE USE DISORDER

THE COMPLETE CBD GUIDE

The Verde Mountain Fund offers a unique opportunity to gain early entry into one of the fastest growing industries in a generation.

CDHA 2016 Fall Symposium. Speaker Handout Files. For registered attendees only

Clinical Education Initiative MEDICAL MARIJUANA 101. Speaker: Patricia Reed, PharmD

Medical Marijuana. Speaker Disclosure Requirements. Share with a Partner 4/10/2015

MARIJUANA & THE EFFECTS ON THE BRAIN

CANNABIS LEGALIZATION: SUPPORT MATERIAL FOR MANITOBA PHYSICIANS

Medical vs Recreational Use of Cannabis. 11 th December 2017

MEDICAL CANNABIS IN MINNESOTA

Medical Marijuana (Cannabis) and Workplace Drug Testing and Safety. Joel Blanchard MD FACEP

Global Legal Cannabis Market: Size, Trends & Forecasts ( ) September 2018

Research: Medical Cannabis

James Donaldson CEO and Executive Director

Medical Marijuana A Primer for Pharmacists

CBD Oil: Benefits, Top Products, Where To Buy, And More

INITIAL PATIENT INTAKE FORM

James McCormack BSc (Pharm), PharmD Professor Faculty of Pharmaceutical Sciences University of British Columbia Vancouver, BC, Canada

9/13/2017. Marijuana and the Brain Matthew Wong, MD Assistant Professor, Department of Neurology, Epilepsy Section. Disclosures.

Q's &A's of Medical Cannabis in Illinois

SECTION V: EMPLOYEES POLICY 5375 MEDICAL MARIJUANA, HEMP & CANNABIDIOL (CBD)

I would like to begin by acknowledging that we are on the ancestral grounds of the Beothuk people

START HERE AWARD-WINNING MEDICAL MARIJUANA DISPENSARIES 1

WHO Expert Committee on Drug Dependence Pre-Review: Cannabis plant and resin. Expert Peer Review 2

PATIENT QUESTIONNAIRE

CAPC/CPNP Coalition Face to Face Meeting October 18, 2018

Legalized Marijuana: Uses, Misuses & Abuses. Disclosures. Objectives. Kennon Heard University of Colorado SOM Dept Of Emergency Medicine

STATUS OF THE NEW CANNABIDIOL PROGRAM

Steven G. Kinsey, PhD Associate Professor, Department of Psychology West Virginia University

Marijuana as Medicine

Medical Cannabis. Danial Schecter, MD, CCFP. Vocational Rehabilitation Association November 7th, Executive Director Cannabinoid Medical Clinic

Weeding Through the Science of Cannabis. Ryan Vandrey, PhD

Cannabis in the Community

Susan Allen-Evenson Hosts: Laura Lagano, MS, RDN, CDN Prepare for the Next Level: Incorporating Holistic Cannabis in the Nutrition Practice

420 ADVISORY MANAGEMENT

Life s brighter under the sun MEDICAL CANNABIS AND GROUP BENEFITS PLAN COVERAGE

COMIRB Protocol Number: PI: Madeline Cole, MS-III Michael Chan, MS-III Dan Matlock, MD MPH. Dear Fellow Medical Student,

Medical Cannabis and OMT

CBD and Your Health.

Compassionate Medical Cannabis: What It Means to the Street Officer

Cannabinoids: access and symptom management in cancer

MD GUIDE TO USING MEDICAL CANNABIS

Cannabis Use: Scope of the Issue

Transcription:

Medical Cannabis MATT WEBSTER DO, MS

Cannabis Sativa One of the oldest used drugs and medicinal remedies Most commonly abused illicit drug in the US There has been increasing access for medicinal MJ use in the US over the past 20 years

What is Marijuana? What we typically think of as MJ is primarily the dried flowers and leaves from plants of the genus Cannabis Sativa. The active compounds in the plant are called cannabinoids. There are hundreds of such compounds but the most important are THC (delta-9-tetrahydrocannabinol) and CBD (cannabidiol).

Cannabinoid Receptor System We have naturally occurring cannabinoids and associated receptors in our bodies and this system was first described in the 1990s. There are different receptors all throughout the body including the CNS and immune system. The two most important receptors are CB-1 and CB-2

CB-1 (THC Receptor) This receptor binds THC Primarily located in the central and peripheral nervous system as well as some in the gut and adipose tissue Causes release of downstream neurotransmitters in the CNS including dopamine which cause euphoria, alter spatial perception, decrease pain perception, stimulate appetite, and may cause a psychoactive effect Causes the typical effects of the high associated with MJ

CB-2 (CBD) Receptor This receptor binds CBD Receptors primarily located in cells of the immune system including solid organs such as the spleen and lymphatics as well as blood based immune cells Helps to decrease inflammation and likely has an anti-cancer effect Chemical most likely to have a positive health effect

Adverse Health Effects of MJ Central Nervous System Memory loss, learning disability Depression, paranoia, addiction Worsening bipolar disorder Anxiety Digestive system Acute hunger ( munchies ) Constipation Respiratory (when smoked) Schizophrenia or other psychoses Bronchitis Increased incidence of suicidal ideation and suicide attempt Cardiovascular system Lung cancer? Pregnancy Increased blood pressure and heart rate Low birth weight infant Increased risk for acute heart attack

Cannabis history in medicine In the early 20 th century was commonly included with many medicinal preparations including cough syrups and lotions 1937 Marijuana Tax Stamp act made it effectively illegal to possess or sell MJ without an expensive tax stamp Controlled Substances Act of 1970 made it a Schedule I controlled drug with no accepted medical use and high potential for abuse

Recent Regulatory Changes 1996 California Proposition 215 The Compassionate Use Act of 1996 Approved for use by seriously ill individuals with MD recommendation Mid 90s-00s US Attorney General relaxed federal law enforcement Rapid rise in medical marijuana licenses 2014 US Department of Justice advised US attorneys not to pursue action against physicians 2018 31 states and Puerta Rico have at least limited medical cannabis access

Synthetic Medical Preparations THC preparations: Dronabinol (Marinol, Syndros)/ Nobilone (Cesamet) Approved for chemo associated N/V and AIDS related weight loss Schedule II CBD: Epidiolex Approved for treatment of childhood epilepsy syndromes Schedule V

Medicinal Cannabis Medical cannabis may be smoked as the natural dried plant or consumed in other preparations to be ingested orally (oil, edibles, capsules, etc) or topically such as lotions CBD:THC ratio is an important concept. Looking for higher CBD than THC content ideally. This is different than recreational MJ which may be 30% THC by weight

Iowa Regulations Iowa Medical Cannabidiol Act was signed in May 2017 allowing for CBD with no more than 3% THC for select approved medical conditions Five dispensaries throughout Iowa will open December 1 Patients will need certification from a PCP of a qualifying condition then apply with the Iowa Department of Public Health for a card allowing purchase of CBD/THC containing products

Iowa Regulations Qualifying conditions include chronic pain, seizures, MS with muscle spasms, Parkinson s Disease, ALS, HIV/AIDs. No smoked or edible CBD/THC will be available but instead preparations will include capsules, oils, and creams Over the counter CBD oil remains illegal in Iowa though is increasingly popular with online ordering and distribution

Conditions with Strong Evidence There is solid evidence that cannabis is effective for the treatment of cancer related pain and the nausea and vomiting associated with chemo Likely is effective for the treatment of spasticity related to MS

Limited Evidence for Effectiveness There is limited evidence that cannabis is effective for treatment of anxiety, insomnia, dementia, ALS, epilepsy, glaucoma Thus, there isn t great clinical evidence that medical cannabis is effective for some of the conditions it is approved for

Summary There is and will be increasing access to cannabis as a medical modality New studies are commencing looking at effectiveness for many conditions It is available in Iowa in a somewhat limited scope Look at the CBD:THC ratio